@ibrance.com
See risks and benefits.
๐ข
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
About
Description
IBRANCEยฎ is a brand that offers a scientific advancement in the treatment of HR+, HER2- metastatic breast cancer. It is the first FDA-approved medication in its class and is not a traditional chemotherapy. IBRANCE is a targeted therapy known as a CDK 4/6 inhibitor.
When taken in combination with certain hormonal therapies, it works to slow down cell growth in both healthy and cancer cells. By doing so, it helps slow the progression of cancer. It is important to note that this treatment may come with side effects, some of which are serious.
IBRANCE is specifically designed for hormone receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. It is suitable for patients with HR+/HER2- mBC, including those who have previously received hormonal therapy and those who haven't. Clinical trials have shown that IBRANCE, when used in combination with aromatase inhibitors or fulvestrant, significantly delays disease progression and reduces the risk of disease progression compared to hormonal therapy alone.
If you have HR+, HER2- metastatic breast cancer, consult with your healthcare team to determine if IBRANCE is the right treatment option for you
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere ๐
All services online
Top brand categories